Abstract
Chronic pain from arthritis continues to be one of the biggest causes of disability and loss of function in the United States today. This is still the case despite many new insights into the pathophysiology of pain, effective treatment approaches, and new, safer medications that can be used long-term. There are many different types of arthritic problems. New disease-modifying agents that are available for some of these types of arthritic diseases, such as rheumatoid arthritis, have the potential to have a substantial impact on improvement in the long-term prognosis. Despite this optimistic outlook, pain often is a significant problem and should be treated whenever it becomes a barrier to function. To complicate treatment for this condition, the most widely used group of medications is under new scrutiny because of concerns regarding long-term detrimental side effects. A complete understanding of the risk factors for NSAIDs, specifically cyclooxygenase-2 inhibitors, is still not available. But published data and new clinical guidelines still suggest that treatment for this large category of diseases can be effective and safe.
Similar content being viewed by others
References
Tanaka TT: A rational approach to the differential diagnosis of arthritic disorders. J Prosthet Dent 1986, 56:727–731.
Meyer K, Tschopp A, Sprott H, Mannion AF: Association between catastrophizing and self-rated pain and disability in patients with chronic low back pain. J Rehabil Med 2009, 41:620–625.
Ross E: The management of pain in arthritis an dthe use of cyclooxgenase-2 inhibitors: new paradigms and insights. Curr Pain Headache Rep 2004, 8:518–522.
Hunter DJ, Lo GH: The management of osteoarthritis: an overview and call to appropriate conservative treatment. Rheum Dis Clin North Am 2008, 34:689–712.
Schlansky B, Hwang JH: Prevention of nonsteroidal antiinflammatory drug-induced gastropathy. J Gastroenterol 2009, 44(Suppl 19):44–52.
Scheiman JM: Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs. Gastroenterol Clin North Am 2009, 38:305–314.
Chou R, Fanciullo GJ, Fine PG, et al.: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009, 10:113–130.
Crosby J: Osteoarthritis: managing without surgery. J Fam Pract 2009, 58:354–361.
Straube S, Tramèr MR, Moore RA, et al.: Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol 2009, 9:41.
Hermann M: Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs. Curr Rheumatol Rep 2009, 11:31–35.
Farkouh ME, Greenberg BP: An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol 2009, 103:1227–1237.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ross, E. Update on the management of pain in arthritis and the use of cyclooxygenase-2 inhibitors. Current Science Inc 13, 455–459 (2009). https://doi.org/10.1007/s11916-009-0074-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11916-009-0074-1